Encompass Health Corporation
EHC
$121.54
$0.250.21%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.67% | 38.01% | 26.85% | 24.84% | 28.28% |
| Total Depreciation and Amortization | 12.66% | 11.27% | 16.49% | 0.41% | 10.02% |
| Total Amortization of Deferred Charges | -- | 2.11% | -- | -- | -- |
| Total Other Non-Cash Items | 13.54% | 58.96% | 7.98% | 7.65% | 50.00% |
| Change in Net Operating Assets | -368.75% | 132.56% | 85.71% | -437.14% | -104.22% |
| Cash from Operations | 20.85% | 38.71% | 24.44% | 5.18% | 4.78% |
| Capital Expenditure | -17.00% | 6.14% | 1.47% | -28.71% | -39.68% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -52.58% | -238.89% | -12.00% | 77.27% | 330.95% |
| Cash from Investing | -22.21% | 2.11% | 0.43% | -23.27% | -24.71% |
| Total Debt Issued | 20.00% | -- | -- | -100.00% | 66.67% |
| Total Debt Repaid | -60.00% | -1,824.59% | -479.63% | 85.70% | -9.65% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -328.93% | -7,400.00% | -1,600.00% | -- | -57.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -13.21% | -14.09% | 0.00% | 0.00% | -1.92% |
| Other Financing Activities | -221.43% | -343.18% | 415.38% | -196.67% | 34.03% |
| Cash from Financing | -221.18% | -404.68% | -36.02% | -14.02% | 30.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -100.44% | -104.86% | 231.25% | -72.91% | 3.95% |